FindTrial
Sign In

A cross-sectional study on the association of peptidoglycan fragments derived from gut microbiota with colorectal cancer

A cross-sectional study on the association of peptidoglycan fragments derived from gut microbiota with colorectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083238
Enrollment
Unknown
Registered
2024-04-18
Start date
2024-04-18
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

CRC:None
CRA:None
CRP:None
Healthy control :None

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) People who underwent total colonoscopy in gastroenteroscopy room. (2) People who agree to participate in this study and are willing to sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Previous diagnosis of malignant tumors other than colorectal cancer. (2) Received any of the following drug treatments within 1 month before sample collection: ? Drugs used for the treatment of colorectal diseases; ? Antibiotics; ?probiotics; ? Laxatives. (3) Patients with a family history of colorectal cancer.

Design outcomes

Primary

MeasureTime frame
Peptidoglycan fragment;—

Countries

China

Contacts

Public ContactXiaolong He

Zhujiang Hospital of Southern Medical University

307660349@qq.com+86 186 2007 1640

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026